CAD 0.07
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 875.45 Thousand | -802.19 Thousand | -2.87 Million | -3.36 Million | -4.23 Million | -1.45 Million |
Net Income | 223.33 Thousand | -3.48 Million | -5.38 Million | -5.95 Million | -8.74 Million | -2.2 Million |
Depreciation & Amortization | 774.83 Thousand | 921.27 Thousand | 1.21 Million | 1.1 Million | 494.51 Thousand | 297.05 Thousand |
Deferred income taxes | - | - | 472.67 Thousand | -623.62 Thousand | -2.76 Million | - |
Stock-based compensation | - | 103.59 Thousand | 464.38 Thousand | 897.56 Thousand | 2.79 Million | 27 Thousand |
Change in working capital | 65.82 Thousand | 1.02 Million | -887.78 Thousand | 177.45 Thousand | -24.33 Thousand | 431.83 Thousand |
Other non-cash items | -188.53 Thousand | 633.67 Thousand | 1.28 Million | 1.02 Million | 4 Million | 118.65 Thousand |
Investing Cash Flow | -23.56 Thousand | -108.83 Thousand | -21.48 Thousand | -2.9 Million | -2.11 Million | -1.68 Million |
Investments in PPE | -23.56 Thousand | -108.83 Thousand | -68.98 Thousand | -2.7 Million | -1.86 Million | -1.63 Million |
Acquisitions | - | - | 47.5 Thousand | 23.75 Thousand | 100.25 Thousand | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 44.27 Thousand | -219.37 Thousand | -358.7 Thousand | -55 Thousand |
Financing Cash Flow | -330.71 Thousand | 373.35 Thousand | 2.81 Million | 2.96 Million | 9.81 Million | 3.64 Million |
Debt repayment | -247.67 Thousand | -2.45 Million | -319.4 Thousand | -64.13 Thousand | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 2.83 Million | 316.87 Thousand | 2.98 Million | 8.95 Million | 3.64 Million |
Other Financing Activities | -83.03 Thousand | 373.35 Thousand | 2.82 Million | 40 Thousand | 855.76 Thousand | 3.64 Million |
Accounts receivables | -873.47 Thousand | 340.23 Thousand | -563.95 Thousand | -375.04 Thousand | 62.61 Thousand | 108.84 Thousand |
Accounts payables | 1.55 Million | 502.13 Thousand | 717.56 Thousand | 588.03 Thousand | -58.37 Thousand | 384.13 Thousand |
Inventory | -670.45 Thousand | 315.64 Thousand | -1.08 Million | -34.54 Thousand | 58.37 Thousand | - |
Other working capital | 58.36 Thousand | -132.02 Thousand | 42.5 Thousand | -1000.00 | -86.95 Thousand | -61.14 Thousand |
Cash at beginning of period | 377.71 Thousand | 915.38 Thousand | 988.67 Thousand | 4.29 Million | 837.6 Thousand | 342.57 Thousand |
Cash at end of period | 898.89 Thousand | 377.71 Thousand | 915.38 Thousand | 988.67 Thousand | 4.29 Million | 837.6 Thousand |
Capital Expenditure | -23.56 Thousand | -108.83 Thousand | -68.98 Thousand | -2.7 Million | -1.86 Million | -1.63 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 521.18 Thousand | -537.66 Thousand | -73.29 Thousand | -3.3 Million | 3.45 Million | 495.03 Thousand |
Free Cash Flow | 851.89 Thousand | -911.02 Thousand | -2.93 Million | -6.07 Million | -6.09 Million | -3.09 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -317.26 Thousand | -1.01 Million | 132.82 Thousand | 223.33 Thousand | 387.64 Thousand | 419.87 Thousand |
Depreciation & Amortization | 175.41 Thousand | 188.99 Thousand | 187.33 Thousand | 774.83 Thousand | 201.52 Thousand | 188.26 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 298.6 Thousand | 1.05 Million | - | - | - | - |
Change in working capital | -633.76 Thousand | 200.09 Thousand | -774.92 Thousand | 65.82 Thousand | -84.25 Thousand | -265.58 Thousand |
Other non-cash items | 32.04 Thousand | 1.22 Million | 2740.00 | -188.53 Thousand | -118 Thousand | 681.37 Thousand |
Investing Cash Flow | -1360.00 | -15.29 Thousand | -48.76 Thousand | -23.56 Thousand | -4633.00 | -13.9 Thousand |
Investments in PPE | -1360.00 | -15.29 Thousand | -48.76 Thousand | -23.56 Thousand | -4633.00 | -13.9 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 263.73 Thousand | 19.73 Thousand | -30.26 Thousand | -330.71 Thousand | -30.26 Thousand | -17.59 Thousand |
Debt repayment | -30.26 Thousand | -60.26 Thousand | -30.26 Thousand | -247.67 Thousand | -30.26 Thousand | -17.59 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 294 Thousand | 80 Thousand | - | - | - | - |
Other Financing Activities | -30.26 Thousand | -30 Thousand | - | - | -30.26 Thousand | -17.59 Thousand |
Accounts receivables | 479.08 Thousand | -157.46 Thousand | -896.08 Thousand | -873.47 Thousand | -336.67 Thousand | 144.23 Thousand |
Accounts payables | -824.5 Thousand | 364 Thousand | 455.57 Thousand | 1.55 Million | 704.97 Thousand | 413.51 Thousand |
Inventory | -195.99 Thousand | 29.33 Thousand | -334.42 Thousand | -670.45 Thousand | -455.54 Thousand | -881.7 Thousand |
Other working capital | -92.35 Thousand | -35.78 Thousand | - | 58.36 Thousand | -870.47 Thousand | 58.36 Thousand |
Cash at beginning of period | 831.57 Thousand | 367.83 Thousand | 898.89 Thousand | 377.71 Thousand | 700.51 Thousand | 408.55 Thousand |
Cash at end of period | 648.97 Thousand | 831.57 Thousand | 367.83 Thousand | 898.89 Thousand | 898.89 Thousand | 700.51 Thousand |
Capital Expenditure | -1360.00 | -15.29 Thousand | -48.76 Thousand | -23.56 Thousand | -4633.00 | -13.9 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -182.6 Thousand | 463.73 Thousand | -531.06 Thousand | 521.18 Thousand | 198.38 Thousand | 291.96 Thousand |
Free Cash Flow | -446.33 Thousand | 444 Thousand | -500.79 Thousand | 851.89 Thousand | 228.65 Thousand | 309.55 Thousand |
NASA
3948
CLEMO
CEG
BODALCHEM
1272